Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis

被引：184
|
作者：
Furue, M. [1 ,2 ,3 ]
Yamamura, K. [1 ,2 ]
Kido-Nakahara, M. [1 ,2 ]
Nakahara, T. [1 ,2 ]
Fukui, Y. [4 ,5 ]
机构：
[1] Kyushu Univ, Dept Dermatol, Grad Sch Med Sci, Fukuoka, Japan
[2] Kyushu Univ, Div Skin Surface Sensing, Grad Sch Med Sci, Fukuoka, Japan
[3] Kyushu Univ, Res & Clin Ctr Yusho & Dioxin, Kyushu Univ Hosp, Fukuoka, Japan
[4] Kyushu Univ, Med Inst Bioregulat, Div Immunogenet, Dept Immunobiol & Neurosci, Fukuoka, Japan
[5] Kyushu Univ, Res Ctr Adv Immunol, Fukuoka, Japan
来源：
ALLERGY | 2018年 / 73卷 / 01期
关键词：
atopic dermatitis; interleukin-31; receptor; pruritus; T helper 2; IL-31; MONOCLONAL-ANTIBODY; CLIENT-OWNED DOGS; T-CELLS; ONCOSTATIN-M; LOKIVETMAB ZTS-00103289; SKIN INFLAMMATION; RELEASE IL-31; DOUBLE-BLIND; ITCH; PLACEBO;
D O I：
10.1111/all.13239
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Atopic dermatitis (AD) is a chronic or chronically relapsing, eczematous, severely pruritic skin disorder associated with skin barrier dysfunction. The lesional skin of AD exhibits T helper 2 (T(H)2)-deviated immune reactions. Interleukin-31 (IL-31), preferentially produced from T(H)2 cells, is a potent pruritogenic cytokine, and its systemic and local administration induces scratching behavior in rodents, dogs and monkeys. Recent clinical trials have revealed that administration of an anti-IL-31 receptor antibody significantly alleviates pruritus in patients with AD. In this review, we summarize recent topics related to IL-31 and its receptor with special references to atopic itch.
引用
收藏
页码：29 / 36
页数：8
相关论文
共 50 条
  • [1] Interleukin-31 and interleukin-31 receptor: New therapeutic targets for atopic dermatitis
    Nakashima, Chisa
    Otsuka, Atsushi
    Kabashima, Kenji
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (04) : 327 - 331
  • [2] Nemolizumab and Atopic Dermatitis: the Interaction Between Interleukin-31 and Interleukin-31 Receptor as a Potential Therapeutic Target for Pruritus in Patients With Atopic Dermatitis
    Nakahara T.
    Furue M.
    Current Treatment Options in Allergy, 2018, 5 (4) : 405 - 414
  • [3] Interleukin-31 as a Clinical Target for Pruritus Treatment
    Kabashima, Kenji
    Irie, Hiroyuki
    FRONTIERS IN MEDICINE, 2021, 8
  • [4] Interleukin-31 and Pruritic Skin
    Furue, Masutaka
    Furue, Mihoko
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (09)
  • [5] Interleukin-31 Receptor A Expression in the Dorsal Root Ganglion of Mice with Atopic Dermatitis
    Arai, Iwao
    Saito, Saburo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [6] Interleukin-31 pathway and its role in atopic dermatitis: a systematic review
    Saleem, Mohammed D.
    Oussedik, Elias
    D'Amber, Veronica
    Feldman, Steven R.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2017, 28 (07) : 591 - 599
  • [7] Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis
    Gonzales, Andrea J.
    Humphrey, William R.
    Messamore, James E.
    Fleck, Timothy J.
    Fici, Gregory J.
    Shelly, John A.
    Teel, Janet F.
    Bammert, Gary F.
    Dunham, Steven A.
    Fuller, Troy E.
    McCall, Robert B.
    VETERINARY DERMATOLOGY, 2013, 24 (01) : 48 - +
  • [8] Correlation between clinical efficacy on pruritus and serum interleukin-31 levels in dogs with atopic dermatitis treated with lokivetmab
    Calesso, J. R.
    Marques, V. S.
    de Carvalho, O. V.
    Costa-Val, A. P.
    POLISH JOURNAL OF VETERINARY SCIENCES, 2023, 26 (02): : 231 - 238
  • [9] Immunohistochemical study of interleukin-31 in patients with atopic dermatitis
    Amin, Tarek E.
    Elfar, Nashwa N.
    Sallam, Fersan A.
    EGYPTIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2018, 38 (02): : 59 - 64
  • [10] Interleukin-31: The Inflammatory Cytokine Connecting Pruritus and Cancer
    Akhtar, Sabah
    Ahmad, Fareed
    Alam, Majid
    Ansari, Abdul Wahid
    Uddin, Shahab
    Steinhoff, Martin
    Buddenkotte, Joerg
    Ahmad, Aamir
    Datsi, Angeliki
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (09):
12345